Contact Us | Sign In | Apply for NAQC Membership
Submit an Abstract

We invite abstracts that align with the meeting tracks and advance knowledge about quitline programs. Presentations should include original research, program highlights, best practices implementation and evaluation, or innovative approaches to promotion, partnerships, or protocols.

 

  • The deadline to submit abstracts is December 31, 2025.
  • Maximum length: 3,000 characters.
  • Abstracts may be submitted as a panel presentation or as a rapid session. Submissions for panel presentations will automatically be considered for rapid sessions.
  • We encourage you to submit abstracts previously shared at other conferences.
  • All primary presenters of accepted abstracts will be required to register for the annual meeting and submit a statement about any conflicts of interest. Any conflicts must be disclosed at the start of a presentation.





Panel presentations will highlight innovations of significant relevance to the quitline community. Abstracts submitted for panel presentations should include sections covering background, approach, results, and conclusions. Presentations will 15-20 minutes during a breakout session.

Rapid sessions may include approaches that lack evaluation data, program highlights or updates, case studies, opportunities to collaborate, or other unique ideas that can advance quitlines. Abstracts should include sections covering background, approach, data (if available), and conclusions or next steps. Rapid sessions will be presented as 5-minute pre-recorded videos with live Q&A.


1500 of 1500 characters remaining
1000 of 1000 characters remaining
3000 of 3000 characters remaining
1000 of 1000 characters remaining
2000 of 2000 characters remaining


All selected speakers are required to complete a Conflict of Interest Disclosure Form prior to presenting at the NAQC Annual Conference.

NAQC will send a link to the COI form if your abstract is accepted for presentation.
All authors on this abstract confirm they not currently, and will not become, engaged in a business relationship with the tobacco industry including e‑cigarette companies, except in the provision of health services such as quitline services to employees of the tobacco industry.